BC, AOCNP, shares strategies to help nurses improve adherence and patient education for oral oncolytic therapies.

Nurse practitioner Beth Faiman outlines nursing strategies to monitor, assess, and manage toxicities associated with ...

A significant reduction of opioid use in patients after colorectal surgery was supported by clinician and patient compliance, ...

Beyond administering CAR T-cell therapy and bispecifics, oncology nurses must apply proactive, supportive care and an understanding of complex treatments.

Panelists discuss how they guide first-line ALK inhibitor selection based on efficacy, tolerability, clinical data, and patient-specific considerations.

Notably, these data demonstrate that a nurse-led clinic could facilitate a system for patients to report their own symptom burden, where previous findings have demonstrated discrepancies exist between ...

Neurotoxicities can be monitored long term with personalized questions, according to Mary Steinbach, DNP, APRN.

The NCCN has added zongertinib to its guidelines for the care of patients with HER2 (ERBB2)-mutated non–small cell lung cancer.

Melissa Rikal, MSN, FNP-BC, AOCNP, explained that adverse effects are common among the available antibody-drug conjugates in breast cancer.